Agenda Cardiomyopathy Symposium 2024

6:30 a.m.

Registration, Breakfast & View Exhibits

7:10-7:55 a.m.

Complimentary Non-CME Breakfast Symposium Supported by Pfizer

Session I

7:55 a.m.

Welcome and Educational Overview

8 a.m.

Diagnosis of Sarcoid

8:15 a.m.

Imaging of Sarcoid

8:30 a.m.

Treatment of Sarcoid

8:45 a.m.

HCM – Diagnosis and Treatment

9 a.m.  

Cardiotoxicity: Anthracyclines

9:15 a.m.

Cardiotoxicity: Immunotherapy

9:30 a.m.

MRI Imaging in Cardiotoxicity

9:45 a.m.

Cancer-Associated Thrombosis

10 a.m.

Comprehensive Management of PE and CTEPH

10:15 a.m.

Panel Discussion/Q&A

10:30 a.m.

Break & View Exhibits

Session II

11 a.m.

When to Suspect Amyloidosis

11:15 a.m.

What and When to Biopsy

11:30 a.m.

When is MGUS Clinically Significant?

11:45 a.m.

Nuclear Imaging in Amyloid

Noon

MRI Imaging in Amyloid

12:15 p.m.

Cardiac Amyloidosis Mimickers

12:30 p.m.

Panel Discussion/Q&A

12:45-1:30 p.m.

Complimentary Non-CME Lunch Symposium Supported by AstraZeneca

Session III

1:30 p.m.

Staging in Amyloid

1:45 p.m.

Racial and Geographic Disparities in Amyloid

2 p.m.

Medical Management of Amyloid

2:15 p.m.

Current Treatment of ATTR: Stabilizers

2:30 p.m.

Current Treatment of ATTR: Silencers

2:45 p.m.

Emerging ATTR Treatments

3 p.m.

AL Amyloidosis: Current Treatments

3:15 p.m.

Panel Discussion/Q&A

3:30 p.m.

Break & View Exhibits

Session IV

3:45 p.m.

Patient Story

4 p.m.

Transplant Options in Amyloidosis

4:15 p.m.

Neuropathy and Autonomic Failure in Amyloid Patients

4:30 p.m.

Managing GI Issues in Amyloidosis

4:45 p.m.

Impact of Carpal Tunnel Surgery

5 p.m.

Panel Discussion/Q&A

5:15 p.m.

Adjourn

**Topics, times, and speakers subject to change